Ratings by Citi (David Hoang)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/1/2024 | Neurocrine Bio. | NBIX | Maintain | Neutral (N/A) |
|
Details | ||
| 7/26/2024 | Acumen Pharmaceuticals, Inc. | ABOS | New Coverage | Buy (N/A) |
3.22 (2.39) |
-25.78% | Details | |
| 7/2/2024 | Longboard Pharmaceuticals Inc | LBPH | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2024 | Sarepta Therapeutics | SRPT | Downgrade | Neutral (Buy) |
163.85 (13.32) |
-91.87% | Details | |
| 6/25/2024 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Buy (N/A) |
|
Details | ||
| 6/24/2024 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Buy (N/A) |
|
Details | ||
| 6/21/2024 | Harmony Biosciences Holdings Inc. | HRMY | New Coverage | Buy (N/A) |
28.89 (34.68) |
20.04% | Details | |
| 6/12/2024 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 6/11/2024 | Sage Therapeutics | SAGE | Maintain | Sell (N/A) |
|
Details | ||
| 6/11/2024 | Longboard Pharmaceuticals Inc | LBPH | Maintain | Buy (N/A) |
|
Details | ||
| 5/29/2024 | Sage Therapeutics | SAGE | New Coverage | Sell (N/A) |
11.78 (8.68) |
-26.32% | Details | |
| 3/26/2024 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2024 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2024 | Voyager Therapeutics | VYGR | New Coverage | Buy (N/A) |
9.10 (6.86) |
-24.62% | Details | |
| 2/29/2024 | Support.com | SPRT | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2024 | Longboard Pharmaceuticals Inc | LBPH | New Coverage | Buy (N/A) |
20.18 (59.98) |
197.22% | Details | |
| 1/4/2024 | Xenon Pharmaceuticals | XENE | New Coverage | Buy (N/A) |
44.91 (52.16) |
16.14% | Details | |
| 12/13/2023 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
| 12/13/2023 | Denali Therapeutics Inc. | DNLI | New Coverage | Buy (N/A) |
18.24 (21.50) |
17.87% | Details | |
| 12/13/2023 | Neurocrine Bio. | NBIX | New Coverage | Neutral (N/A) |
118.51 (141.33) |
19.26% | Details | |
| 12/13/2023 | Acadia Pharmaceuticals | ACAD | New Coverage | Buy (N/A) |
21.09 (20.94) |
-0.71% | Details | |
| 12/13/2023 | Support.com | SPRT | New Coverage | Buy (N/A) |
11.80 (11.80) |
0% | Details | |
| 12/13/2023 | Axsome Therapeutics | AXSM | New Coverage | Buy (N/A) |
69.65 (256.50) |
268.27% | Details | |
| 12/12/2023 | Karuna Therapeutics Inc. | KRTX | New Coverage | Buy (N/A) |
203.71 (329.83) |
61.91% | Details |
